SPONSOR
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Total Trials
9
Recruiting
9
Phases
Phase 2, Phase 1, Phase 3
Conditions studied: Colorectal CancerAdvanced Solid TumorsLocally Advanced or Metastatic Urothelial CarcinomaLocally Advanced Rectal CancerWidespread Small Cell Lung CancerAdvanced Solid TumorNon-small Cell Lung CancerNSCLC
NCT07071714 Phase 2
Recruiting
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
Colorectal Cancer
NCT06907628 Phase 1
Recruiting
A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors
Advanced Solid Tumors
NCT07393542 Phase 3
Recruiting
A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma
Locally Advanced or Metastatic Urothelial Carcinoma
NCT06443489 Phase 1
Recruiting
A Trial of SHR-4849 in Advanced Solid Tumors
Advanced Solid Tumors
NCT05300269 Phase 2
Recruiting
SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer
Locally Advanced Rectal Cancer
NCT07009457 Phase 1
Recruiting
Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer
Widespread Small Cell Lung Cancer
NCT05819684 Phase 1
Recruiting
A Study of SHR-4602 in Subjects With Advanced Malignant Solid Tumors
Advanced Solid Tumor
NCT07183189 Phase 3
Recruiting
A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC
Non-small Cell Lung Cancer
NCT06844474 Phase 2
Recruiting
A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC
NSCLC